Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
Background. Hearing is essential in child development. Cisplatin which is a common chemotherapy used in many pediatric solid-tumor protocols cause various degrees of ototoxicity. Several risk factors for cisplatin-induced ototoxicity have been reported, including race and age. This study aimed to ev...
Saved in:
Main Authors: | Tatpong Sriyapai, Kanthong Thongyai, Kamon Phuakpet, Nassawee Vathana, Jassada Buaboonnam, Kleebsabai Sanpakit |
---|---|
Other Authors: | Siriraj Hospital |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/74908 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
by: Sriyapai T.
Published: (2023) -
Long-term effectiveness, safety, and tolerability of twice-daily dosing with deferasirox in children with transfusion-dependent thalassemias unresponsive to standard once-daily dosing
by: Jassada Buaboonnam, et al.
Published: (2022) -
Outcomes of pediatric retinoblastoma treated with ICEV regimen: A single-center study
by: Jassada Buaboonnam, et al.
Published: (2020) -
Using of deferasirox and deferoxamine in refractory iron overload thalassemia
by: Chayamon Takpradit, et al.
Published: (2022) -
Hematologic malignancies associated with mediastinal germ cell tumors: 10 years' experience at Thailand's national pediatric tertiary referral center
by: Panjarat Sowithayasakul, et al.
Published: (2019)